Beta Thalassemia Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Technology (Perinatal Testing, Complete Blood Count (CBC), DNA Testing, Others); Treatment (Blood Transfusion, Iron Chelation Therapy, Folic Acid Supplements, Others); End User (Hospitals and Clinics, Diagnostic Centers, Others) and Geography
Report Code: TIPRE00018491 No. of Pages: 150 Category: Medical Device Status: Upcoming
MARKET INTRODUCTION
Beta thalassemia is a diseased state of blood in which there is a reduced hemoglobin production. Hemoglobin is a protein containing iron and is present in Red blood cells, and the primary function of hemoglobin is to carry oxygen to the body cells throughout the body. Low hemoglobin content in beta-thalassemia patients usually leads to the lack of oxygen in many parts of the body. Due to the shortage of blood in the body patient, skin becomes pale yellow, and the other symptoms like weakness and fatigue are prominent. The risk of abnormal blood clotting highly persists in the patients suffering from beta-thalassemia. Beta thalassemia testing helps in the diagnosis of beta-thalassemia, thereby reducing morbidity and mortality rates.
MARKET DYNAMICS
The beta thalassemia testing market has shown a significant evolution over the forecast period. The rising incidence of beta thalassemia majorly drives the rise of the beta thalassemia testing market. Patients with insufficient hemoglobin suffer from thalassemia. For instance, thalassemia affects approximately 4.4 of every 10,000 live births throughout the world. Increasing pipeline drugs in beta thalassemia is expected to drive the growth of the market. There are about 15 pipeline products under clinical trials for the treatment of beta thalassemia. For instance, in December 2016, Kiadis Pharma announced Phase I/II clinical trial with ATIR201 for thalassemia. Moreover, the offering of prenatal testing and the use of advanced molecular testing is expected to create lucrative opportunities for the new players entering the beta thalassemia testing market. However, stringent regulatory policies and high treatment costs are likely to restrain the market growth.
MARKET SCOPE
The "Beta Thalassemia Testing Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry's medical device, with a specific focus on the global market trend analysis. This report outlines the beta thalassemia testing market with detailed market segmentation by technology, treatment, and end-user. The beta thalassemia testing market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on the leading players' market status in the beta thalassemia testing market and provides key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the technology, treatment, and end user. Based on the technology, the market is segmented as perinatal testing, complete blood count (CBC), DNA testing, and others. Based on the treatment, the segmentation of the market is into blood transfusion, iron chelation therapy, folic acid supplements, and others. Based on end user, the segmentation of the market is into hospitals and clinics, diagnostic centers, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the beta thalassemia testing market based on various segments. The report also consists of market size and forecast estimates from the year 2018 to2027with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The beta thalassemia testing market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the beta thalassemia testing market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the Beta thalassemia testing market in these regions.
The report contains critical developments in the beta thalassemia testing market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the beta thalassemia testing market are estimated to have profitable growth opportunities in the coming years with the higher demand for beta thalassemia testing in the global market. Given below is the list of a few companies engaged in the beta thalassemia testing market.
The report also offers key players' profiles in the beta thalassemia testing market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.
Beta thalassemia is a diseased state of blood in which there is a reduced hemoglobin production. Hemoglobin is a protein containing iron and is present in Red blood cells, and the primary function of hemoglobin is to carry oxygen to the body cells throughout the body. Low hemoglobin content in beta-thalassemia patients usually leads to the lack of oxygen in many parts of the body. Due to the shortage of blood in the body patient, skin becomes pale yellow, and the other symptoms like weakness and fatigue are prominent. The risk of abnormal blood clotting highly persists in the patients suffering from beta-thalassemia. Beta thalassemia testing helps in the diagnosis of beta-thalassemia, thereby reducing morbidity and mortality rates.
MARKET DYNAMICS
The beta thalassemia testing market has shown a significant evolution over the forecast period. The rising incidence of beta thalassemia majorly drives the rise of the beta thalassemia testing market. Patients with insufficient hemoglobin suffer from thalassemia. For instance, thalassemia affects approximately 4.4 of every 10,000 live births throughout the world. Increasing pipeline drugs in beta thalassemia is expected to drive the growth of the market. There are about 15 pipeline products under clinical trials for the treatment of beta thalassemia. For instance, in December 2016, Kiadis Pharma announced Phase I/II clinical trial with ATIR201 for thalassemia. Moreover, the offering of prenatal testing and the use of advanced molecular testing is expected to create lucrative opportunities for the new players entering the beta thalassemia testing market. However, stringent regulatory policies and high treatment costs are likely to restrain the market growth.
MARKET SCOPE
The "Beta Thalassemia Testing Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry's medical device, with a specific focus on the global market trend analysis. This report outlines the beta thalassemia testing market with detailed market segmentation by technology, treatment, and end-user. The beta thalassemia testing market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on the leading players' market status in the beta thalassemia testing market and provides key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the technology, treatment, and end user. Based on the technology, the market is segmented as perinatal testing, complete blood count (CBC), DNA testing, and others. Based on the treatment, the segmentation of the market is into blood transfusion, iron chelation therapy, folic acid supplements, and others. Based on end user, the segmentation of the market is into hospitals and clinics, diagnostic centers, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the beta thalassemia testing market based on various segments. The report also consists of market size and forecast estimates from the year 2018 to2027with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The beta thalassemia testing market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the beta thalassemia testing market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the Beta thalassemia testing market in these regions.
The report contains critical developments in the beta thalassemia testing market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the beta thalassemia testing market are estimated to have profitable growth opportunities in the coming years with the higher demand for beta thalassemia testing in the global market. Given below is the list of a few companies engaged in the beta thalassemia testing market.
The report also offers key players' profiles in the beta thalassemia testing market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Trinity Biotech Plc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Chromsystems Instruments & Chemicals GmbH.
- BioMedomics, Inc.
- CapitalBio Technology Inc.
- Randox Laboratories Ltd.
- EKF Diagnostics Holdings plc
- Fujirebio
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Beta Thalassemia Testing Market - By Technology
1.3.2 Beta Thalassemia Testing Market - By Treatment
1.3.3 Beta Thalassemia Testing Market - By End User
1.3.4 Beta Thalassemia Testing Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BETA THALASSEMIA TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BETA THALASSEMIA TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BETA THALASSEMIA TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. BETA THALASSEMIA TESTING - GLOBAL MARKET OVERVIEW
6.2. BETA THALASSEMIA TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BETA THALASSEMIA TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. PERINATAL TESTING
7.3.1. Overview
7.3.2. Perinatal Testing Market Forecast and Analysis
7.4. COMPLETE BLOOD COUNT (CBC)
7.4.1. Overview
7.4.2. Complete Blood Count (CBC) Market Forecast and Analysis
7.5. DNA TESTING
7.5.1. Overview
7.5.2. DNA Testing Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. BETA THALASSEMIA TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
8.1. OVERVIEW
8.2. TREATMENT MARKET FORECASTS AND ANALYSIS
8.3. BLOOD TRANSFUSION
8.3.1. Overview
8.3.2. Blood Transfusion Market Forecast and Analysis
8.4. IRON CHELATION THERAPY
8.4.1. Overview
8.4.2. Iron Chelation Therapy Market Forecast and Analysis
8.5. FOLIC ACID SUPPLEMENTS
8.5.1. Overview
8.5.2. Folic Acid Supplements Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. BETA THALASSEMIA TESTING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. BETA THALASSEMIA TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Beta Thalassemia Testing Market Overview
10.1.2 North America Beta Thalassemia Testing Market Forecasts and Analysis
10.1.3 North America Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.1.4 North America Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.1.5 North America Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.1.6 North America Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.1.6.1 United States Beta Thalassemia Testing Market
10.1.6.1.1 United States Beta Thalassemia Testing Market by Technology
10.1.6.1.2 United States Beta Thalassemia Testing Market by Treatment
10.1.6.1.3 United States Beta Thalassemia Testing Market by End User
10.1.6.2 Canada Beta Thalassemia Testing Market
10.1.6.2.1 Canada Beta Thalassemia Testing Market by Technology
10.1.6.2.2 Canada Beta Thalassemia Testing Market by Treatment
10.1.6.2.3 Canada Beta Thalassemia Testing Market by End User
10.1.6.3 Mexico Beta Thalassemia Testing Market
10.1.6.3.1 Mexico Beta Thalassemia Testing Market by Technology
10.1.6.3.2 Mexico Beta Thalassemia Testing Market by Treatment
10.1.6.3.3 Mexico Beta Thalassemia Testing Market by End User
10.2. EUROPE
10.2.1 Europe Beta Thalassemia Testing Market Overview
10.2.2 Europe Beta Thalassemia Testing Market Forecasts and Analysis
10.2.3 Europe Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.2.4 Europe Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.2.5 Europe Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.2.6 Europe Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Beta Thalassemia Testing Market
10.2.6.1.1 Germany Beta Thalassemia Testing Market by Technology
10.2.6.1.2 Germany Beta Thalassemia Testing Market by Treatment
10.2.6.1.3 Germany Beta Thalassemia Testing Market by End User
10.2.6.2 France Beta Thalassemia Testing Market
10.2.6.2.1 France Beta Thalassemia Testing Market by Technology
10.2.6.2.2 France Beta Thalassemia Testing Market by Treatment
10.2.6.2.3 France Beta Thalassemia Testing Market by End User
10.2.6.3 Italy Beta Thalassemia Testing Market
10.2.6.3.1 Italy Beta Thalassemia Testing Market by Technology
10.2.6.3.2 Italy Beta Thalassemia Testing Market by Treatment
10.2.6.3.3 Italy Beta Thalassemia Testing Market by End User
10.2.6.4 Spain Beta Thalassemia Testing Market
10.2.6.4.1 Spain Beta Thalassemia Testing Market by Technology
10.2.6.4.2 Spain Beta Thalassemia Testing Market by Treatment
10.2.6.4.3 Spain Beta Thalassemia Testing Market by End User
10.2.6.5 United Kingdom Beta Thalassemia Testing Market
10.2.6.5.1 United Kingdom Beta Thalassemia Testing Market by Technology
10.2.6.5.2 United Kingdom Beta Thalassemia Testing Market by Treatment
10.2.6.5.3 United Kingdom Beta Thalassemia Testing Market by End User
10.2.6.6 Rest of Europe Beta Thalassemia Testing Market
10.2.6.6.1 Rest of Europe Beta Thalassemia Testing Market by Technology
10.2.6.6.2 Rest of Europe Beta Thalassemia Testing Market by Treatment
10.2.6.6.3 Rest of Europe Beta Thalassemia Testing Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Beta Thalassemia Testing Market Overview
10.3.2 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis
10.3.3 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.3.5 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Beta Thalassemia Testing Market
10.3.6.1.1 Australia Beta Thalassemia Testing Market by Technology
10.3.6.1.2 Australia Beta Thalassemia Testing Market by Treatment
10.3.6.1.3 Australia Beta Thalassemia Testing Market by End User
10.3.6.2 China Beta Thalassemia Testing Market
10.3.6.2.1 China Beta Thalassemia Testing Market by Technology
10.3.6.2.2 China Beta Thalassemia Testing Market by Treatment
10.3.6.2.3 China Beta Thalassemia Testing Market by End User
10.3.6.3 India Beta Thalassemia Testing Market
10.3.6.3.1 India Beta Thalassemia Testing Market by Technology
10.3.6.3.2 India Beta Thalassemia Testing Market by Treatment
10.3.6.3.3 India Beta Thalassemia Testing Market by End User
10.3.6.4 Japan Beta Thalassemia Testing Market
10.3.6.4.1 Japan Beta Thalassemia Testing Market by Technology
10.3.6.4.2 Japan Beta Thalassemia Testing Market by Treatment
10.3.6.4.3 Japan Beta Thalassemia Testing Market by End User
10.3.6.5 South Korea Beta Thalassemia Testing Market
10.3.6.5.1 South Korea Beta Thalassemia Testing Market by Technology
10.3.6.5.2 South Korea Beta Thalassemia Testing Market by Treatment
10.3.6.5.3 South Korea Beta Thalassemia Testing Market by End User
10.3.6.6 Rest of Asia-Pacific Beta Thalassemia Testing Market
10.3.6.6.1 Rest of Asia-Pacific Beta Thalassemia Testing Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Beta Thalassemia Testing Market by Treatment
10.3.6.6.3 Rest of Asia-Pacific Beta Thalassemia Testing Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Beta Thalassemia Testing Market Overview
10.4.2 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis
10.4.3 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.4.5 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Beta Thalassemia Testing Market
10.4.6.1.1 South Africa Beta Thalassemia Testing Market by Technology
10.4.6.1.2 South Africa Beta Thalassemia Testing Market by Treatment
10.4.6.1.3 South Africa Beta Thalassemia Testing Market by End User
10.4.6.2 Saudi Arabia Beta Thalassemia Testing Market
10.4.6.2.1 Saudi Arabia Beta Thalassemia Testing Market by Technology
10.4.6.2.2 Saudi Arabia Beta Thalassemia Testing Market by Treatment
10.4.6.2.3 Saudi Arabia Beta Thalassemia Testing Market by End User
10.4.6.3 U.A.E Beta Thalassemia Testing Market
10.4.6.3.1 U.A.E Beta Thalassemia Testing Market by Technology
10.4.6.3.2 U.A.E Beta Thalassemia Testing Market by Treatment
10.4.6.3.3 U.A.E Beta Thalassemia Testing Market by End User
10.4.6.4 Rest of Middle East and Africa Beta Thalassemia Testing Market
10.4.6.4.1 Rest of Middle East and Africa Beta Thalassemia Testing Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Beta Thalassemia Testing Market by Treatment
10.4.6.4.3 Rest of Middle East and Africa Beta Thalassemia Testing Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Beta Thalassemia Testing Market Overview
10.5.2 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis
10.5.3 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.5.5 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.5.6 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Beta Thalassemia Testing Market
10.5.6.1.1 Brazil Beta Thalassemia Testing Market by Technology
10.5.6.1.2 Brazil Beta Thalassemia Testing Market by Treatment
10.5.6.1.3 Brazil Beta Thalassemia Testing Market by End User
10.5.6.2 Argentina Beta Thalassemia Testing Market
10.5.6.2.1 Argentina Beta Thalassemia Testing Market by Technology
10.5.6.2.2 Argentina Beta Thalassemia Testing Market by Treatment
10.5.6.2.3 Argentina Beta Thalassemia Testing Market by End User
10.5.6.3 Rest of South and Central America Beta Thalassemia Testing Market
10.5.6.3.1 Rest of South and Central America Beta Thalassemia Testing Market by Technology
10.5.6.3.2 Rest of South and Central America Beta Thalassemia Testing Market by Treatment
10.5.6.3.3 Rest of South and Central America Beta Thalassemia Testing Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BETA THALASSEMIA TESTING MARKET, KEY COMPANY PROFILES
12.1. TRINITY BIOTECH PLC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIO-RAD LABORATORIES, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. THERMO FISHER SCIENTIFIC INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PERKINELMER INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CHROMSYSTEMS INSTRUMENTS & CHEMICALS GMBH.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIOMEDOMICS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CAPITALBIO TECHNOLOGY INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. RANDOX LABORATORIES LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EKF DIAGNOSTICS HOLDINGS PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. FUJIREBIO
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Beta Thalassemia Testing Market - By Technology
1.3.2 Beta Thalassemia Testing Market - By Treatment
1.3.3 Beta Thalassemia Testing Market - By End User
1.3.4 Beta Thalassemia Testing Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BETA THALASSEMIA TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BETA THALASSEMIA TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BETA THALASSEMIA TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. BETA THALASSEMIA TESTING - GLOBAL MARKET OVERVIEW
6.2. BETA THALASSEMIA TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BETA THALASSEMIA TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. PERINATAL TESTING
7.3.1. Overview
7.3.2. Perinatal Testing Market Forecast and Analysis
7.4. COMPLETE BLOOD COUNT (CBC)
7.4.1. Overview
7.4.2. Complete Blood Count (CBC) Market Forecast and Analysis
7.5. DNA TESTING
7.5.1. Overview
7.5.2. DNA Testing Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. BETA THALASSEMIA TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
8.1. OVERVIEW
8.2. TREATMENT MARKET FORECASTS AND ANALYSIS
8.3. BLOOD TRANSFUSION
8.3.1. Overview
8.3.2. Blood Transfusion Market Forecast and Analysis
8.4. IRON CHELATION THERAPY
8.4.1. Overview
8.4.2. Iron Chelation Therapy Market Forecast and Analysis
8.5. FOLIC ACID SUPPLEMENTS
8.5.1. Overview
8.5.2. Folic Acid Supplements Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. BETA THALASSEMIA TESTING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. BETA THALASSEMIA TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Beta Thalassemia Testing Market Overview
10.1.2 North America Beta Thalassemia Testing Market Forecasts and Analysis
10.1.3 North America Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.1.4 North America Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.1.5 North America Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.1.6 North America Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.1.6.1 United States Beta Thalassemia Testing Market
10.1.6.1.1 United States Beta Thalassemia Testing Market by Technology
10.1.6.1.2 United States Beta Thalassemia Testing Market by Treatment
10.1.6.1.3 United States Beta Thalassemia Testing Market by End User
10.1.6.2 Canada Beta Thalassemia Testing Market
10.1.6.2.1 Canada Beta Thalassemia Testing Market by Technology
10.1.6.2.2 Canada Beta Thalassemia Testing Market by Treatment
10.1.6.2.3 Canada Beta Thalassemia Testing Market by End User
10.1.6.3 Mexico Beta Thalassemia Testing Market
10.1.6.3.1 Mexico Beta Thalassemia Testing Market by Technology
10.1.6.3.2 Mexico Beta Thalassemia Testing Market by Treatment
10.1.6.3.3 Mexico Beta Thalassemia Testing Market by End User
10.2. EUROPE
10.2.1 Europe Beta Thalassemia Testing Market Overview
10.2.2 Europe Beta Thalassemia Testing Market Forecasts and Analysis
10.2.3 Europe Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.2.4 Europe Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.2.5 Europe Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.2.6 Europe Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Beta Thalassemia Testing Market
10.2.6.1.1 Germany Beta Thalassemia Testing Market by Technology
10.2.6.1.2 Germany Beta Thalassemia Testing Market by Treatment
10.2.6.1.3 Germany Beta Thalassemia Testing Market by End User
10.2.6.2 France Beta Thalassemia Testing Market
10.2.6.2.1 France Beta Thalassemia Testing Market by Technology
10.2.6.2.2 France Beta Thalassemia Testing Market by Treatment
10.2.6.2.3 France Beta Thalassemia Testing Market by End User
10.2.6.3 Italy Beta Thalassemia Testing Market
10.2.6.3.1 Italy Beta Thalassemia Testing Market by Technology
10.2.6.3.2 Italy Beta Thalassemia Testing Market by Treatment
10.2.6.3.3 Italy Beta Thalassemia Testing Market by End User
10.2.6.4 Spain Beta Thalassemia Testing Market
10.2.6.4.1 Spain Beta Thalassemia Testing Market by Technology
10.2.6.4.2 Spain Beta Thalassemia Testing Market by Treatment
10.2.6.4.3 Spain Beta Thalassemia Testing Market by End User
10.2.6.5 United Kingdom Beta Thalassemia Testing Market
10.2.6.5.1 United Kingdom Beta Thalassemia Testing Market by Technology
10.2.6.5.2 United Kingdom Beta Thalassemia Testing Market by Treatment
10.2.6.5.3 United Kingdom Beta Thalassemia Testing Market by End User
10.2.6.6 Rest of Europe Beta Thalassemia Testing Market
10.2.6.6.1 Rest of Europe Beta Thalassemia Testing Market by Technology
10.2.6.6.2 Rest of Europe Beta Thalassemia Testing Market by Treatment
10.2.6.6.3 Rest of Europe Beta Thalassemia Testing Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Beta Thalassemia Testing Market Overview
10.3.2 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis
10.3.3 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.3.5 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Beta Thalassemia Testing Market
10.3.6.1.1 Australia Beta Thalassemia Testing Market by Technology
10.3.6.1.2 Australia Beta Thalassemia Testing Market by Treatment
10.3.6.1.3 Australia Beta Thalassemia Testing Market by End User
10.3.6.2 China Beta Thalassemia Testing Market
10.3.6.2.1 China Beta Thalassemia Testing Market by Technology
10.3.6.2.2 China Beta Thalassemia Testing Market by Treatment
10.3.6.2.3 China Beta Thalassemia Testing Market by End User
10.3.6.3 India Beta Thalassemia Testing Market
10.3.6.3.1 India Beta Thalassemia Testing Market by Technology
10.3.6.3.2 India Beta Thalassemia Testing Market by Treatment
10.3.6.3.3 India Beta Thalassemia Testing Market by End User
10.3.6.4 Japan Beta Thalassemia Testing Market
10.3.6.4.1 Japan Beta Thalassemia Testing Market by Technology
10.3.6.4.2 Japan Beta Thalassemia Testing Market by Treatment
10.3.6.4.3 Japan Beta Thalassemia Testing Market by End User
10.3.6.5 South Korea Beta Thalassemia Testing Market
10.3.6.5.1 South Korea Beta Thalassemia Testing Market by Technology
10.3.6.5.2 South Korea Beta Thalassemia Testing Market by Treatment
10.3.6.5.3 South Korea Beta Thalassemia Testing Market by End User
10.3.6.6 Rest of Asia-Pacific Beta Thalassemia Testing Market
10.3.6.6.1 Rest of Asia-Pacific Beta Thalassemia Testing Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Beta Thalassemia Testing Market by Treatment
10.3.6.6.3 Rest of Asia-Pacific Beta Thalassemia Testing Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Beta Thalassemia Testing Market Overview
10.4.2 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis
10.4.3 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.4.5 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Beta Thalassemia Testing Market
10.4.6.1.1 South Africa Beta Thalassemia Testing Market by Technology
10.4.6.1.2 South Africa Beta Thalassemia Testing Market by Treatment
10.4.6.1.3 South Africa Beta Thalassemia Testing Market by End User
10.4.6.2 Saudi Arabia Beta Thalassemia Testing Market
10.4.6.2.1 Saudi Arabia Beta Thalassemia Testing Market by Technology
10.4.6.2.2 Saudi Arabia Beta Thalassemia Testing Market by Treatment
10.4.6.2.3 Saudi Arabia Beta Thalassemia Testing Market by End User
10.4.6.3 U.A.E Beta Thalassemia Testing Market
10.4.6.3.1 U.A.E Beta Thalassemia Testing Market by Technology
10.4.6.3.2 U.A.E Beta Thalassemia Testing Market by Treatment
10.4.6.3.3 U.A.E Beta Thalassemia Testing Market by End User
10.4.6.4 Rest of Middle East and Africa Beta Thalassemia Testing Market
10.4.6.4.1 Rest of Middle East and Africa Beta Thalassemia Testing Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Beta Thalassemia Testing Market by Treatment
10.4.6.4.3 Rest of Middle East and Africa Beta Thalassemia Testing Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Beta Thalassemia Testing Market Overview
10.5.2 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis
10.5.3 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis - By Treatment
10.5.5 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis - By End User
10.5.6 South and Central America Beta Thalassemia Testing Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Beta Thalassemia Testing Market
10.5.6.1.1 Brazil Beta Thalassemia Testing Market by Technology
10.5.6.1.2 Brazil Beta Thalassemia Testing Market by Treatment
10.5.6.1.3 Brazil Beta Thalassemia Testing Market by End User
10.5.6.2 Argentina Beta Thalassemia Testing Market
10.5.6.2.1 Argentina Beta Thalassemia Testing Market by Technology
10.5.6.2.2 Argentina Beta Thalassemia Testing Market by Treatment
10.5.6.2.3 Argentina Beta Thalassemia Testing Market by End User
10.5.6.3 Rest of South and Central America Beta Thalassemia Testing Market
10.5.6.3.1 Rest of South and Central America Beta Thalassemia Testing Market by Technology
10.5.6.3.2 Rest of South and Central America Beta Thalassemia Testing Market by Treatment
10.5.6.3.3 Rest of South and Central America Beta Thalassemia Testing Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BETA THALASSEMIA TESTING MARKET, KEY COMPANY PROFILES
12.1. TRINITY BIOTECH PLC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIO-RAD LABORATORIES, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. THERMO FISHER SCIENTIFIC INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PERKINELMER INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CHROMSYSTEMS INSTRUMENTS & CHEMICALS GMBH.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIOMEDOMICS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CAPITALBIO TECHNOLOGY INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. RANDOX LABORATORIES LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EKF DIAGNOSTICS HOLDINGS PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. FUJIREBIO
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Trinity Biotech Plc.
2. Bio-Rad Laboratories, Inc.
3. Thermo Fisher Scientific Inc.
4. PerkinElmer Inc.
5. Chromsystems Instruments & Chemicals GmbH.
6. BioMedomics, Inc.
7. CapitalBio Technology Inc.
8. Randox Laboratories Ltd.
9. EKF Diagnostics Holdings plc
10. Fujirebio
1. Trinity Biotech Plc.
2. Bio-Rad Laboratories, Inc.
3. Thermo Fisher Scientific Inc.
4. PerkinElmer Inc.
5. Chromsystems Instruments & Chemicals GmbH.
6. BioMedomics, Inc.
7. CapitalBio Technology Inc.
8. Randox Laboratories Ltd.
9. EKF Diagnostics Holdings plc
10. Fujirebio